Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Interest Expenses (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Interest Expenses for 3 consecutive years, with $28000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 92.09% to $28000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $607000.0, a 54.94% decrease, with the full-year FY2024 number at $1.4 million, down 52.45% from a year prior.
  • Interest Expenses was $28000.0 for Q3 2025 at Mereo BioPharma, up from $24000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.0 million in Q2 2023 to a low of $24000.0 in Q2 2025.
  • A 3-year average of $407545.5 and a median of $352000.0 in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: grew 6.53% in 2024, then tumbled 92.75% in 2025.
  • Mereo BioPharma's Interest Expenses stood at $352000.0 in 2023, then increased by 6.53% to $375000.0 in 2024, then crashed by 92.53% to $28000.0 in 2025.
  • Per Business Quant, the three most recent readings for MREO's Interest Expenses are $28000.0 (Q3 2025), $24000.0 (Q2 2025), and $180000.0 (Q1 2025).